119 related articles for article (PubMed ID: 19500569)
1. Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells.
Kim A; Son M; Kim KI; Yang Y; Song EY; Lee HG; Lim JS
Exp Cell Res; 2009 Nov; 315(19):3325-35. PubMed ID: 19500569
[TBL] [Abstract][Full Text] [Related]
2. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract][Full Text] [Related]
3. Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis.
Morita T; Hayashi K
Mol Cancer Res; 2018 May; 16(5):880-893. PubMed ID: 29330296
[TBL] [Abstract][Full Text] [Related]
4. Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression.
Choi JH; Han EH; Hwang YP; Choi JM; Choi CY; Chung YC; Seo JK; Jeong HG
Food Chem Toxicol; 2010 Feb; 48(2):564-71. PubMed ID: 19922761
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of alpha-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kappaB/cyclooxygenase-2 pathway.
Liu GS; Liu LF; Lin CJ; Tseng JC; Chuang MJ; Lam HC; Lee JK; Yang LC; Chan JH; Howng SL; Tai MH
Mol Pharmacol; 2006 Feb; 69(2):440-51. PubMed ID: 16269535
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of invasion and experimental metastasis of murine melanoma cells by Ipomoea obscura (L.) is mediated through the down-regulation of inflammatory mediators and matrix-metalloproteinases.
Hamsa TP; Kuttan G
J Exp Ther Oncol; 2011; 9(2):139-51. PubMed ID: 21699021
[TBL] [Abstract][Full Text] [Related]
7. Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation.
Huang D; Wang S; Wang A; Chen X; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):788-94. PubMed ID: 27521796
[TBL] [Abstract][Full Text] [Related]
8. Thymosin β4 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition.
Fu X; Cui P; Chen F; Xu J; Gong L; Jiang L; Zhang D; Xiao Y
Mol Med Rep; 2015 Jul; 12(1):127-32. PubMed ID: 25695679
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation via the expression of thymosin beta-4.
Lee JW; Ryu YK; Ji YH; Kang JH; Moon EY
Oncotarget; 2015; 6(12):9820-33. PubMed ID: 25888632
[TBL] [Abstract][Full Text] [Related]
10. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
11. Role of thymosin beta4 in tumor metastasis and angiogenesis.
Cha HJ; Jeong MJ; Kleinman HK
J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of actin-sequestering protein, thymosin β-4 and hypoxia inducible factor-1α in tumor cell migration.
Ryu YK; Im YS; Moon EY
Oncol Rep; 2010 Nov; 24(5):1389-94. PubMed ID: 20878135
[TBL] [Abstract][Full Text] [Related]
13. Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells.
Zhao Y; Zhang D; Wang S; Tao L; Wang A; Chen W; Zhu Z; Zheng S; Gao X; Lu Y
PLoS One; 2013; 8(2):e56557. PubMed ID: 23437168
[TBL] [Abstract][Full Text] [Related]
14. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
[TBL] [Abstract][Full Text] [Related]
15. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2873-80. PubMed ID: 9743348
[TBL] [Abstract][Full Text] [Related]
16. Thymosin β4: a potential molecular target for tumor therapy.
Xiao Y; Chen Y; Wen J; Yan W; Zhou K; Cai W
Crit Rev Eukaryot Gene Expr; 2012; 22(2):109-16. PubMed ID: 22856429
[TBL] [Abstract][Full Text] [Related]
17. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.
Zhang L; Tao L; Shi T; Zhang F; Sheng X; Cao Y; Zheng S; Wang A; Qian W; Jiang L; Lu Y
IUBMB Life; 2015 Oct; 67(10):778-88. PubMed ID: 26452780
[TBL] [Abstract][Full Text] [Related]
18. Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells.
Ricci-Vitiani L; Mollinari C; di Martino S; Biffoni M; Pilozzi E; Pagliuca A; de Stefano MC; Circo R; Merlo D; De Maria R; Garaci E
FASEB J; 2010 Nov; 24(11):4291-301. PubMed ID: 20566622
[TBL] [Abstract][Full Text] [Related]
19. Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone.
Murata J; Ayukawa K; Ogasawara M; Watanabe H; Saiki I
Int J Cancer; 1999 Mar; 80(6):889-95. PubMed ID: 10074923
[TBL] [Abstract][Full Text] [Related]
20. Effects of thymosin β4-derived peptides on migration and invasion of ovarian cancer cells.
Yoon HJ; Oh YL; Ko EJ; Kang A; Eo WK; Kim KH; Lee JY; Kim A; Chun S; Kim H; Ock MS; Cha HJ
Genes Genomics; 2021 Aug; 43(8):987-993. PubMed ID: 34170491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
